Neos Therapeutics, Inc. (NEOS) has 18 open-market insider trades by 13 insiders since 2015. The most active filer is James F. Watson, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| James E. Flynn | 10% | — | 1 | $4.2M | 2015-07-28 |
| James F. Watson | 10% Owner | — | 4 | $915K | 2016-04-15 |
| Presidio Partners 2007, L.P. | 10% Owner | — | 1 | $593K | 2016-04-15 |
| Capital Corp Essex | 10% | — | 1 | $450K | 2015-07-28 |
| Presidio Partners 2007 GP, LLC | 10% Owner | — | 1 | $357K | 2016-04-20 |
| Jack W. Schuler | 10% | — | 1 | $300K | 2015-07-28 |
| Alan L. Heller | Dir | — | 2 | $276K | 2021-03-19 |
| Gregory J. Robitaille | Dir | — | 1 | $112K | 2021-03-19 |
| Juergen Martens | — | — | 1 | $99K | 2017-05-01 |
| Richard I. Eisenstadt | CFO | — | 2 | $61K | 2021-03-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Richard I. Eisenstadt | CFO | Buy | $11K | 2018-12-12 |
| Gerald W. McLaughlin | CEO | Buy | $36K | 2018-12-06 |
| Gerald W. McLaughlin | CEO | Buy | $15K | 2018-12-04 |
| Alan L. Heller | Director | Buy | $200K | 2018-11-08 |
| Bryant Fong | Director | Buy | $10K | 2016-08-31 |
| Richard I. Eisenstadt | CFO | Buy | $51K | 2016-08-25 |
Companies that share insiders with NEOS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Juergen Martens | — | Buy | $99K | 2016-06-13 |
| Thomas P. McDonnell | Chief Commercial Officer | Buy | $23K | 2016-05-19 |
| Alan L. Heller | Director | Buy | $76K | 2016-05-19 |
| Gregory J. Robitaille | Director | Buy | $112K | 2016-05-18 |
| Presidio Partners 2007 GP, LLC | 10% Owner | Sell | $357K | 2016-04-18 |
| James F. Watson | 10% Owner | Sell | $181K | 2016-04-15 |
| James F. Watson | 10% Owner | Sell | $272K | 2016-04-14 |
| James F. Watson | 10% | Sell | $337K | 2016-04-13 |
| James F. Watson | 10% Owner | Sell | $126K | 2016-04-13 |